Table 3.
Univariate logistic regression analysis of nutritional risk in GC patients by NRS2002 (scores<3 points vs. ≥ 3 points).
Variables | Odds ratios (95% CI) | P Value |
---|---|---|
Gender | 1.065 (0.769,1.477) | 0.704 |
Age(<70 y vs. ≥70y) | 4.823 (2.470,9.416) | <0.001 |
hs-CRP(<1.00mg/L vs. ≥1.00mg/L) | 2.063 (1.500,2.839) | <0.001 |
HB | 0.984 (0.978,0.991) | <0.001 |
ALB | 0.852 (0.817,0.890) | <0.001 |
PAB | 0.991 (0.988,0.994) | <0.001 |
TP | 0.917 (0.890,0.944) | <0.001 |
TLC | 0.686 (0.550,0.856) | 0.001 |
BMI | 0.738 (0.691,0.787) | <0.001 |
BWL(≤2.4%/>2.4%) | 4.432 (3.035,6.471) | <0.001 |
Grade(Well/moderate vs. Poor/undifferentiated) | 1.290 (0.896,1.858) | 0.171 |
TMD(<5cm/≥5cm) | 2.026 (1.435,2.861) | <0.001 |
PNI(Negtive/Positive) | 1.920 (1.389,2.655) | <0.001 |
LVI(Negtive/Positive) | 1.809 (1.303,2.510) | <0.001 |
DTI(T0-1 vs. T2-4) | 2.850 (1.935,4.198) | <0.001 |
LNM(Negtive/Positive) | 1.729 (1.240,2.412) | 0.001 |
pTNM stages (0/I/II vs. III/IV) | 1.782 (1.298,2.447) | <0.001 |
CI, confidence interval; hs-CRP, hypersensitive C-reactive protein; HB, hemoglobin; ALB, albumin; PAB, prealbumin; TP, total protein; TLC, total lymphocyte count; BMI, body mass index; BWL, body weight loss; TMD, tumor maximum diameter; PNI, peripheral nerve invasion; LVI, lymph-vascular invasion; DTI, depth of tumor invasion; LNM, lymph node metastasis.